These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2310699)

  • 1. Antithrombin III and procoagulant activity: sex differences and effects of the menopause.
    Meade TW; Dyer S; Howarth DJ; Imeson JD; Stirling Y
    Br J Haematol; 1990 Jan; 74(1):77-81. PubMed ID: 2310699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III and arterial disease.
    Meade TW; Cooper J; Miller GJ; Howarth DJ; Stirling Y
    Lancet; 1991 Oct; 338(8771):850-1. PubMed ID: 1681216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population.
    Amin H; Mohsin S; Aslam M; Hussain S; Saeed T; Ullah MI; Sami W
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):745-50. PubMed ID: 23135380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal status and haemostatic variables.
    Meade TW; Haines AP; Imeson JD; Stirling Y; Thompson SG
    Lancet; 1983 Jan; 1(8314-5):22-4. PubMed ID: 6129369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sex hormones and haemostatic factors in healthy middle-aged men.
    Bonithon-Kopp C; Scarabin PY; Bara L; Castanier M; Jacqueson A; Roger M
    Atherosclerosis; 1988 May; 71(1):71-6. PubMed ID: 3377881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of demographic factors on antithrombin III activity in a healthy population.
    Tait RC; Walker ID; Islam SI; McCall F; Conkie JA; Mitchell R; Davidson JF
    Br J Haematol; 1993 Jul; 84(3):476-80. PubMed ID: 8217800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state.
    Wright D; Poller L; Thomson JM; Burrows GE; Hirst CF; Sidebotham A
    Thromb Res; 1997 Mar; 85(6):455-64. PubMed ID: 9101638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VII activation and menopausal status.
    Scarabin PY; Bonithon-Kopp C; Bara L; Malmejac A; Guize L; Samama M
    Thromb Res; 1990 Jan; 57(2):227-34. PubMed ID: 2315887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
    Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
    Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
    De Stavola BL; Meade TW
    J Thromb Haemost; 2007 Mar; 5(3):461-71. PubMed ID: 17137470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
    Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
    Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic factors according to menopausal status and use of hormone replacement therapy.
    Meilahn EN; Kuller LH; Matthews KA; Kiss JE
    Ann Epidemiol; 1992 Jul; 2(4):445-55. PubMed ID: 1342295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
    Meade TW; Imeson J; Stirling Y
    Lancet; 1987 Oct; 2(8566):986-8. PubMed ID: 2889958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
    Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
    Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII.
    Gordon EM; Williams SR; Frenchek B; Mazur CA; Speroff L
    J Lab Clin Med; 1988 Jan; 111(1):52-6. PubMed ID: 3335825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.